Sandip Kuikel

Dr. Sandip Kuikel

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2022 in Health Science Reports
Verified
Journal Article
Open access
SKSandip Kuikel
Sandip Kuikel
NPNibesh Pathak
Nibesh Pathak
SPSagar Poudel
Sagar Poudel
STSital Thapa
Sital Thapa
SBShiva Lal Bhattarai
Shiva Lal Bhattarai
KPKundan Raj Pandey
Kundan Raj Pandey
Background: Community‐acquired pneumonia (CAP) is the acute infection of lung tissue in an immunocompetent who acquired it from the community. Its incidence and mortality are significant and require a marker to predict the severity and mortality in these patients. Neutrophil–lymphocyte ratio (NLR) is a simple, cheap, and easy‐to‐use marker and this study describes its role in predicting the adverse outcome in patients with CAP.Methods: PubMed, EMBASE, and Google Scholar were used to search for related studies on February 8, 2021. A total of 186 articles were retrieved upon detailed searching in the databases and search engines. After a series of removing duplicate articles, title and abstract screening, and full‐text review; nine articles were found eligible and included in the study. The data from each article were collected in MS Excel and the findings were summarized in this manuscript.Results: The total number of patients analyzed in this systematic review is 3340. The mean age of the patient in the included studies ranged from 61 to 90.4 years. All studies had adverse outcomes as the endpoint of the study, which included in‐hospital mortality or intensive care unit (ICU) admission or deterioration from medium and low risk to high risk or 30 days' mortality. The prevalence of endpoint ranged from 5.8% to 44.8%. NLR with a cutoff value of more than 10 was shown to predict mortality compared to C‐reactive protein levels, white blood cell count, neutrophil count, lymphocyte level, Pneumonia Severity Index (PSI) level, PSI class, procalcitonin, and CURB‐65 (Confusion, Respiratory rate, Blood pressure, 65 years of age and older) in most of the studies.Conclusion: NLR is a simple, easily measured yet promising marker for predicting outcomes in patients with CAP.

10 June 2022 in American Journal of Infection Control
Verified
Journal Article
Closed access
SGSubarna Giri
Subarna Giri
AGAnup Ghimire
Anup Ghimire
AMAshish Mishra
Ashish Mishra
KAKshitiz Acharya
Kshitiz Acharya
SKSandip Kuikel
Sandip Kuikel
SMShyam Kumar Mishra
Shyam Kumar Mishra

1 January 2021 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
SKSandip Kuikel
Sandip Kuikel
SSSanjib Shrestha
Sanjib Shrestha
STSital Thapa
Sital Thapa
NMNarendra Maharjan
Narendra Maharjan
BKBishnu Prasad Kandel
Bishnu Prasad Kandel
PLPaleswan Joshi Lakhey
Paleswan Joshi Lakhey
Introduction and importance: Morgagni Hernia is a congenital diaphragmatic hernia but can rarely present in adults. It occurs due to a congenital defect in the development of the diaphragm. Here we present a case of symptomatic Morgagni hernia diagnosed in a 53 years' female. Case presentation: A 53 years' female presented with recurrent chest symptoms and was found to have bowel contents herniated into the right hemithorax on chest X-ray and CECT. Reduction of hernia was done laparoscopically and the hernia was repaired with non-absorbable suture in an interrupted manner. Clinical discussion: Morgagni hernias are mostly diagnosed incidentally on a chest radiograph or can present with cardiorespiratory or abdominal symptoms. Our case was an adult who was diagnosed to have Morgagni hernia presenting with chest symptoms. The investigation of choice to diagnose and evaluate this condition is CECT of chest and repair of hernia without the use mesh is advised in asymptomatic cases also due to feared complications like strangulation and incarceration. Conclusion: The treatment of Morgagni Hernia is primary surgical repair which can be done either transthoracically or transabdominally. It is advised that surgical repair should be done even in asymptomatic cases. Highlights:

1 August 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
PSPrezma Shrestha
Prezma Shrestha
SKSandip Kuikel
Sandip Kuikel
SBSunita Bajracharya
Sunita Bajracharya
AGAnup Ghimire
Anup Ghimire
RSRoshan Shrestha
Roshan Shrestha
ANAmit Sharma Nepal
Amit Sharma Nepal
The prevalence and paradigm of antenatal heart disease are contrasting between high-income, industrialized, and low- and middle-income countries. In this systematic review, we report the prevalence of heart disease and its spectrum in pregnant women of South Asia. We searched through different electronic databases (PubMed, Google-scholar, Embase, Cochrane Library) to locate relevant articles. Studies with sufficient data that met our inclusion criteria were included. Two reviewers independently screened the articles. Discrepancies were resolved by other reviewers. Subsequently, data extraction was done using a standardized form and quality assessment of studies using the Joanna Briggs Institute tool. Meta-analysis was done using R software. After various stages of screening 25 studies were included in the final quantitative synthesis. The pooled prevalence of heart disease among pregnant women was 1.46% (95% CI 0.99–2.01). Among those with heart disease, 70.25% (95% CI 64.87–75.38) had Rheumatic heart disease and 18.10% (95% CI 14.39–22.12) had congenital heart disease. The pooled prevalence of preterm labor and delivery among pregnant women with heart disease was 17.63% (95% CI 12.18–23.80). Similarly, the pooled maternal and fetal mortality rates were 26.14 (95% CI 12.47–43.55) and 50.48 (95% CI 29.59–75.83) per 1000 pregnant women with heart disease respectively. As pregnancy, itself is a prolonged state of physiologic stress, heart disease further adds to the risk both for the mother and fetus. Having such a high prevalence, efforts must be made to detect and closely monitor the condition antenatally, and decisions should be made according to the clinical conditions of the patient.

27 September 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
KAKshitiz Acharya
Kshitiz Acharya
DPDiptee Poudel
Diptee Poudel
SDSampada Dahal
Sampada Dahal
SKSandip Kuikel
Sandip Kuikel
AAAshmita Adhikari
Ashmita Adhikari
Large cystic masses are rare in pregnancy. Corpus luteum cysts and theca lutein cysts are common are most common among all. Ovarian masses are usually discovered as an incidental finding during routine obstetric ultrasonography. Management depends upon the size of the mass, and the symptoms produced by the mass. Our case describes an incidental finding of a large ovarian cyst during the second trimester, in a 24-year-old female patient. Per abdominal examination revealed a huge mass in the epigastrium, left hypogastrium, and left lumbar region, along with 20 weeks sized uterus. Ultrasonography revealed a cystic mass of 11.9 cm × 11.7 cm X 15.9 cm, with multiple septations and cystic areas. After other baseline investigations, she was planned for surgical removal of the mass. Upon histopathologic examination after surgical excision, the mass was found to be mucinous cystadenoma. Large ovarian masses are uncommon during pregnancy. The most common complications of ovarian masses in pregnancy are torsion, rupture, infection, or malpresentation of the fetus. Surgical management can be done if the mass presents with acute symptoms like torsion, or if the size of the mass is greater than 5 cm. Non-obstetric surgery for cyst removal can be done electively during the second trimester, or irrespective of the period of gestation if there are acute symptoms. Large ovarian masses are usually rare during pregnancy. It is necessary to properly evaluate the case of ovarian masses during pregnancy, to decide the appropriate line of management.

26 December 2022 in The Clinical Respiratory Journal
Verified
Journal Article
Open access
SKSandip Kuikel
Sandip Kuikel
AMAman Mishra
Aman Mishra
RRRohit Rauniyar
Rohit Rauniyar
SYShikha Yadav
Shikha Yadav
STSahil Thapaliya
Sahil Thapaliya
RRRahul Rauniyar
Rahul Rauniyar
Background: COVID‐19 disease‐related coagulopathy and thromboembolic complication, an important aspect of the disease pathophysiology, are frequent and associated with poor outcomes, particularly significant in hospitalized patients. Undoubtedly, anticoagulation forms a cornerstone for the management of hospitalized COVID‐19 patients, but the appropriate dosing has been inconclusive and a subject of research. We aim to review existing literature and compare safety and efficacy outcomes of prophylactic and therapeutic dose anticoagulation in such patients.Methods: We did a systematic review and meta‐analysis to compare the efficacy and safety of prophylactic dose anticoagulation when compared with therapeutic dosing in hospitalized COVID‐19 patients. We searched PubMed, Google Scholar, EMBASE and COCHRANE databases from 2019 to 2021, without any restriction by language. We screened records, extracted data and assessed the risk of bias in the studies. RCTs that directly compare therapeutic and prophylactic anticoagulants dosing and are not placebo‐controlled trials were included. Analyses of data were conducted using the Mantel–Haenszel random‐effects model (DerSimonian–Laird analysis). The study is registered with PROSPERO (CRD42021265948).Results: We included three studies in the final quantitative analysis. The incidence of thromboembolic events in therapeutic anticoagulation was lower in comparison with prophylactic anticoagulation in hospitalized COVID‐19 patients and reached statistical significance [RR 1·45, 95% CI (1.07, 1.97) I2 –0%], whereas major bleeding as an adverse event was found lower in prophylactic anticoagulation in comparison with therapeutic anticoagulation that was statistically significant [RR 0·42, 95% CI(0.19, 0.93) I2 –0%].Conclusion: Our study shows that therapeutic dose anticoagulation is more effective in preventing thromboembolic events than prophylactic dose but significantly increases the risk of major bleeding as an adverse event. So, the risk–benefit ratio must be considered while using either of them.